{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:11:51Z","timestamp":1761174711589,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T00:00:00Z","timestamp":1417478400000},"content-version":"vor","delay-in-days":3683,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1111\/j.1469-0691.2004.00982.x","type":"journal-article","created":{"date-parts":[[2004,11,2]],"date-time":"2004-11-02T10:21:05Z","timestamp":1099390865000},"page":"1033-1035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy"],"prefix":"10.1016","volume":"10","author":[{"given":"T.","family":"Cheasty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.","family":"Threlfall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2004.00982.x_bib1","series-title":"Manson's tropical diseases","first-page":"824","article-title":"Gastrointestinal bacteria","author":"Shears","year":"2003"},{"key":"10.1111\/j.1469-0691.2004.00982.x_bib2","series-title":"Principles and practice of infectious disease","first-page":"1716","article-title":"Bacillary dysentery","author":"Dupont","year":"1985"},{"key":"10.1111\/j.1469-0691.2004.00982.x_bib3","first-page":"575","article-title":"Increase in drug resistance among Shigella dysenteriae, Sh","volume":"283","author":"Gross","year":"1981","journal-title":"Flexneri and Sh. boydii. BMJ"},{"key":"10.1111\/j.1469-0691.2004.00982.x_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/30.3.243","article-title":"Rethinking options for the treatment of shigellosis","volume":"30","author":"Bennish","year":"1992","journal-title":"J Antimicrob Chemother"},{"year":"2000","series-title":"Control of communicable disease manual","key":"10.1111\/j.1469-0691.2004.00982.x_bib5"},{"key":"10.1111\/j.1469-0691.2004.00982.x_bib6","series-title":"Methods in practical laboratory bacteriology","first-page":"73","article-title":"Testing for resistance to antibacterial drugs","author":"Frost","year":"1994"},{"key":"10.1111\/j.1469-0691.2004.00982.x_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/mdr.1998.4.57","article-title":"Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy","volume":"4","author":"Cheasty","year":"1998","journal-title":"Microb Drug Resist"},{"key":"10.1111\/j.1469-0691.2004.00982.x_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.47.2.827-829.2003","article-title":"Is it time to change fluoroquinolone breakpoints for Salmonella spp.?","volume":"47","author":"Aarestrup","year":"2003","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14637228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14637228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:17:53Z","timestamp":1761117473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14637228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S1198743X14637228"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2004.00982.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"type":"print","value":"1198-743X"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1469-0691.2004.00982.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}